Efficacy of injectable toltrazuril-iron combination product and oral toltrazuril against early experimental infection of suckling piglets with Cystoisospora suis

Table 2 Statistical evaluation: P-values are given for different parameters (Kruskal–Wallis test and Mann–Whitney U-test when P < α; α = 0.05). Degrees of freedom df = 2 for all parameters

Parameter	Forceris® vs control	Baycox® vs control	Forceris® vs Baycox®	χ ²
Oocyst excretion
Number of days with AF detectable excretion	< 0.0001	< 0.0001	> 0.9999	34.6
Number of days with MM countable excretion	< 0.0001	< 0.0001	> 0.9999	34.6
AF detectable excretion present or not	< 0.0001	< 0.0001	> 0.9999	36.0
MM countable excretion present or not	< 0.0001	< 0.0001	> 0.9999	36.0
Area under the curve for oocysts per gram of faeces	< 0.0001	< 0.0001	> 0.9999	185.7
Faecal consistency
Area under the curve for FS	< 0.0001	< 0.0001	0.3810	20.7
Number of days with diarrhoea	< 0.0001	< 0.0001	> 0.9999	29.3
Diarrhoea present or not	< 0.0001	< 0.0001	> 0.9999	31.9
Body weight development
Body weights 1st dol	Kruskal–Wallis test: α = 0.8795			0.257
Body weights 8th dol	Kruskal–Wallis test: α = 0.1554			3.723
Body weights 15th dol	0.0069	0.0041	0.9703	9.659
Body weights 22nd dol	Kruskal–Wallis test: α = 0.1440			4.518
Body weights 29th dol	Kruskal–Wallis test: α = 0.3730			1.972
Daily body weight gain 8th–29th dol	Kruskal–Wallis test: α = 0.2891			2.482
Daily body weight gain 8th–15th dol	< 0.0001	< 0.0001	0.9999	18.56

ISSN: 1756-3305